Fosamax Lawyers Specializing In Fosamax Lawsuits
Fosamax Femur / Thigh Fractures
If you took Fosamax and suffered from a femur fracture or thigh fracture
it may have been caused by your ingestion of Fosamax. Fosamax may
have weakened your bone’s strength even if your bone density has increased, the knowledgeable Fosamax Lawyers at Pulaski & Middleman can help!
On October 13, 2010, the U.S. Food and Drug Administration (FDA) issued a femur fracture warning informing patients and health care providers about the risk of atypical thigh bone (femur) fractures in patients who take bisphosphonates, such as Bisphosphonates a popular class of drugs used to prevent and treat osteoporosis in post-menopausal women have been increasingly linked to two rare types of leg fracture that cuts straight across the upper thighbone after little or no trauma. These thigh fractures, known as subtrochanteric and diaphyseal femur fractures, typically occur as a result of a serious car accident, falling from a high height, or occur in the elderly and frail due to some from of impact and or truama.
But an alarming number of reports recently show these highly unusual fracture patterns occurring in healthy women who have had no trauma but have been using bisphosphonates, such as Fosamax, for five years or more and experienced a thighbone fracture after a low or no impact activity.
If you or a loved one has taken Fosamax for over 5 years and has suffered from a
femur /thigh fracture, please contact us today.
Osteonecrosis of the Jaw ONJ
Fosamax is a type of drug known as bisphosphonates. Individuals using Fosamax or other bisphosphonates should attempt to steer clear of tooth extractions and other major dental work while on the drugs. A connection between Fosamax and other bisphosphonates and a serious bone disease called Osteonecrosis of the Jaw (ONJ) was found. Osteonecrosis of the Jaw (ONJ) is also known as Dead Jaw. This finding was published in the Journal of Oral and Maxillofacial Surgeons, and it prompted the US Food and Drug Administration (FDA) and the manufacturer of Fosamax to issue a warning to health care professionals on September 24, 2004.
Osteonecrosis of the Jaw (ONJ) is a condition in which the bone tissue in the jaw fails to heal after minor trauma such as a tooth extraction, causing the bone to be exposed. The exposure can eventually lead to infection and fracture and may require long-term antibiotic therapy or surgery to remove the dying bone tissue. Experts say that prevention and early treatment of patients using bisphosphonates such as Fosamax is extremely important in preserving the jawbone.
About Fosamax
Fosamax (Generic: Alendronate), manufactured by Merck, gained FDA approval in 1995. Fosamax is prescribed to treat osteoporosis and Paget’s disease. Fosamax is a type of drug known as bisphosphonates. Bisphosphonates are commonly used in tablet form such as Fosamax (generic: Alendronate Sodium) to prevent and treat osteoporosis in post-menopausal women. Stronger forms of bisphosphonates are commonly used in the management of advanced cancers that have metastasized to the bone, where the disease often causes bone pain and possibly even fractures.
If you or a loved one took Fosamax and suffered side effects, please contact our law firm at 1-800-BAD-DRUG for a free consultation.
Note – Do not stop taking any medications without first consulting your doctor.
